Blood Brain Barrier Technologies Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Technology (Bispecific Antibody RMT Approach, Trojan Horse Approach, Increasing Permeability, Passive Diffusion, Other Non-Invasive BBB Technologies); Application (Alzheimers Disease, Epilepsy, Parkinsons Disease, Multiple Sclerosis, Hunters Syndrome, Brain Cancer, Other)

Report Code: TIPRE00021883 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

The brain is surrounded by protective fluid known as cerebrospinal fluid and a protective membrane called the meninges. Similar another protective element is the blood brain barrier. this is a barrier between the brain's blood vessels and the cells and other components that together make up brain tissue. The blood brain barrier protects against disease-causing pathogens/toxins that may be present in the blood. It blocks the passage of foreign substances entering the brain tissue. It also blocks the passage of life-saving drugs used to treat neurodegeneration and neuroinflammation events. Thus, different technologies are used to deliver drugs across blood brain barrier.

MARKET DYNAMICS

The blood brain barrier technologies market is expected to grow owing to growing prevalence of neurodegeneration and neuroinflammation events, rising geriatric population and increasing funds for research and development for the development of new drugs and delivery devices for neurological diseases. Moreover, growing pharmaceutical industry in developing nations may create growth opportunities for the market.

MARKET SCOPE

The "Blood Brain Barrier Technologies Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of blood brain barrier technologies market with detailed market segmentation by technology and application. The blood brain barrier technologies market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in blood brain barrier technologies market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The blood brain barrier technologies market is segmented on the basis of technology and application. Based on technology, the market is segmented as trojan horse approach, bispecific antibody RMT approach, increasing the permeability of BBB, passive diffusion, and other non-invasive BBB technologies. Based on application, the market is segmented as alzheimer's disease, epilepsy, parkinson's disease, multiple sclerosis, hunter's syndrome, brain cancer, and other.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the blood brain barrier technologies market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The blood brain barrier technologies market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting blood brain barrier technologies market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the blood brain barrier technologies market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the blood brain barrier technologies market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from blood brain barrier technologies market are anticipated to have lucrative growth opportunities in the future with the rising demand for blood brain barrier technologies in the global market. Below mentioned is the list of few companies engaged in the blood brain barrier technologies market.

The report also includes the profiles of key players in blood brain barrier technologies market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Teva Pharmaceuticals Industries Ltd.
  •   F. Hoffmann La-Roche Ltd.
  •   Eli Lilly and Company
  •   Fabre-Kramer Pharmaceuticals Inc.
  •   Bristol-Myers Squibb Company
  •   Pfizer Inc.
  •   biOasia Technologies Inc.
  •   Cypress Biosciences Inc.
  •   Janssen Pharmaceutical N.V.
  •   NeuroVive Pharmaceutical AB

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Blood Brain Barrier Technologies Market - By Technology
1.3.2 Blood Brain Barrier Technologies Market - By Application
1.3.3 Blood Brain Barrier Technologies Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. BLOOD BRAIN BARRIER TECHNOLOGIES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. BLOOD BRAIN BARRIER TECHNOLOGIES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. BLOOD BRAIN BARRIER TECHNOLOGIES MARKET - GLOBAL MARKET ANALYSIS
6.1. BLOOD BRAIN BARRIER TECHNOLOGIES - GLOBAL MARKET OVERVIEW
6.2. BLOOD BRAIN BARRIER TECHNOLOGIES - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. BLOOD BRAIN BARRIER TECHNOLOGIES MARKET - REVENUE AND FORECASTS TO 2028 - TECHNOLOGY
7.1. OVERVIEW
7.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
7.3. BISPECIFIC ANTIBODY RMT APPROACH
7.3.1. Overview
7.3.2. Bispecific Antibody RMT Approach Market Forecast and Analysis
7.4. TROJAN HORSE APPROACH
7.4.1. Overview
7.4.2. Trojan Horse Approach Market Forecast and Analysis
7.5. INCREASING PERMEABILITY
7.5.1. Overview
7.5.2. Increasing Permeability Market Forecast and Analysis
7.6. PASSIVE DIFFUSION
7.6.1. Overview
7.6.2. Passive Diffusion Market Forecast and Analysis
7.7. OTHER NON-INVASIVE BBB TECHNOLOGIES
7.7.1. Overview
7.7.2. Other Non-Invasive BBB Technologies Market Forecast and Analysis
8. BLOOD BRAIN BARRIER TECHNOLOGIES MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. ALZHEIMER'S DISEASE
8.3.1. Overview
8.3.2. Alzheimer's Disease Market Forecast and Analysis
8.4. EPILEPSY
8.4.1. Overview
8.4.2. Epilepsy Market Forecast and Analysis
8.5. PARKINSON'S DISEASE
8.5.1. Overview
8.5.2. Parkinson's Disease Market Forecast and Analysis
8.6. MULTIPLE SCLEROSIS
8.6.1. Overview
8.6.2. Multiple Sclerosis Market Forecast and Analysis
8.7. HUNTER'S SYNDROME
8.7.1. Overview
8.7.2. Hunter's Syndrome Market Forecast and Analysis
8.8. BRAIN CANCER
8.8.1. Overview
8.8.2. Brain Cancer Market Forecast and Analysis
8.9. OTHER
8.9.1. Overview
8.9.2. Other Market Forecast and Analysis
9. BLOOD BRAIN BARRIER TECHNOLOGIES MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Blood Brain Barrier Technologies Market Overview
9.1.2 North America Blood Brain Barrier Technologies Market Forecasts and Analysis
9.1.3 North America Blood Brain Barrier Technologies Market Forecasts and Analysis - By Technology
9.1.4 North America Blood Brain Barrier Technologies Market Forecasts and Analysis - By Application
9.1.5 North America Blood Brain Barrier Technologies Market Forecasts and Analysis - By Countries
9.1.5.1 United States Blood Brain Barrier Technologies Market
9.1.5.1.1 United States Blood Brain Barrier Technologies Market by Technology
9.1.5.1.2 United States Blood Brain Barrier Technologies Market by Application
9.1.5.2 Canada Blood Brain Barrier Technologies Market
9.1.5.2.1 Canada Blood Brain Barrier Technologies Market by Technology
9.1.5.2.2 Canada Blood Brain Barrier Technologies Market by Application
9.1.5.3 Mexico Blood Brain Barrier Technologies Market
9.1.5.3.1 Mexico Blood Brain Barrier Technologies Market by Technology
9.1.5.3.2 Mexico Blood Brain Barrier Technologies Market by Application
9.2. EUROPE
9.2.1 Europe Blood Brain Barrier Technologies Market Overview
9.2.2 Europe Blood Brain Barrier Technologies Market Forecasts and Analysis
9.2.3 Europe Blood Brain Barrier Technologies Market Forecasts and Analysis - By Technology
9.2.4 Europe Blood Brain Barrier Technologies Market Forecasts and Analysis - By Application
9.2.5 Europe Blood Brain Barrier Technologies Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Blood Brain Barrier Technologies Market
9.2.5.1.1 Germany Blood Brain Barrier Technologies Market by Technology
9.2.5.1.2 Germany Blood Brain Barrier Technologies Market by Application
9.2.5.2 France Blood Brain Barrier Technologies Market
9.2.5.2.1 France Blood Brain Barrier Technologies Market by Technology
9.2.5.2.2 France Blood Brain Barrier Technologies Market by Application
9.2.5.3 Italy Blood Brain Barrier Technologies Market
9.2.5.3.1 Italy Blood Brain Barrier Technologies Market by Technology
9.2.5.3.2 Italy Blood Brain Barrier Technologies Market by Application
9.2.5.4 Spain Blood Brain Barrier Technologies Market
9.2.5.4.1 Spain Blood Brain Barrier Technologies Market by Technology
9.2.5.4.2 Spain Blood Brain Barrier Technologies Market by Application
9.2.5.5 United Kingdom Blood Brain Barrier Technologies Market
9.2.5.5.1 United Kingdom Blood Brain Barrier Technologies Market by Technology
9.2.5.5.2 United Kingdom Blood Brain Barrier Technologies Market by Application
9.2.5.6 Rest of Europe Blood Brain Barrier Technologies Market
9.2.5.6.1 Rest of Europe Blood Brain Barrier Technologies Market by Technology
9.2.5.6.2 Rest of Europe Blood Brain Barrier Technologies Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Blood Brain Barrier Technologies Market Overview
9.3.2 Asia-Pacific Blood Brain Barrier Technologies Market Forecasts and Analysis
9.3.3 Asia-Pacific Blood Brain Barrier Technologies Market Forecasts and Analysis - By Technology
9.3.4 Asia-Pacific Blood Brain Barrier Technologies Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Blood Brain Barrier Technologies Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Blood Brain Barrier Technologies Market
9.3.5.1.1 Australia Blood Brain Barrier Technologies Market by Technology
9.3.5.1.2 Australia Blood Brain Barrier Technologies Market by Application
9.3.5.2 China Blood Brain Barrier Technologies Market
9.3.5.2.1 China Blood Brain Barrier Technologies Market by Technology
9.3.5.2.2 China Blood Brain Barrier Technologies Market by Application
9.3.5.3 India Blood Brain Barrier Technologies Market
9.3.5.3.1 India Blood Brain Barrier Technologies Market by Technology
9.3.5.3.2 India Blood Brain Barrier Technologies Market by Application
9.3.5.4 Japan Blood Brain Barrier Technologies Market
9.3.5.4.1 Japan Blood Brain Barrier Technologies Market by Technology
9.3.5.4.2 Japan Blood Brain Barrier Technologies Market by Application
9.3.5.5 South Korea Blood Brain Barrier Technologies Market
9.3.5.5.1 South Korea Blood Brain Barrier Technologies Market by Technology
9.3.5.5.2 South Korea Blood Brain Barrier Technologies Market by Application
9.3.5.6 Rest of Asia-Pacific Blood Brain Barrier Technologies Market
9.3.5.6.1 Rest of Asia-Pacific Blood Brain Barrier Technologies Market by Technology
9.3.5.6.2 Rest of Asia-Pacific Blood Brain Barrier Technologies Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Blood Brain Barrier Technologies Market Overview
9.4.2 Middle East and Africa Blood Brain Barrier Technologies Market Forecasts and Analysis
9.4.3 Middle East and Africa Blood Brain Barrier Technologies Market Forecasts and Analysis - By Technology
9.4.4 Middle East and Africa Blood Brain Barrier Technologies Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Blood Brain Barrier Technologies Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Blood Brain Barrier Technologies Market
9.4.5.1.1 South Africa Blood Brain Barrier Technologies Market by Technology
9.4.5.1.2 South Africa Blood Brain Barrier Technologies Market by Application
9.4.5.2 Saudi Arabia Blood Brain Barrier Technologies Market
9.4.5.2.1 Saudi Arabia Blood Brain Barrier Technologies Market by Technology
9.4.5.2.2 Saudi Arabia Blood Brain Barrier Technologies Market by Application
9.4.5.3 U.A.E Blood Brain Barrier Technologies Market
9.4.5.3.1 U.A.E Blood Brain Barrier Technologies Market by Technology
9.4.5.3.2 U.A.E Blood Brain Barrier Technologies Market by Application
9.4.5.4 Rest of Middle East and Africa Blood Brain Barrier Technologies Market
9.4.5.4.1 Rest of Middle East and Africa Blood Brain Barrier Technologies Market by Technology
9.4.5.4.2 Rest of Middle East and Africa Blood Brain Barrier Technologies Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Blood Brain Barrier Technologies Market Overview
9.5.2 South and Central America Blood Brain Barrier Technologies Market Forecasts and Analysis
9.5.3 South and Central America Blood Brain Barrier Technologies Market Forecasts and Analysis - By Technology
9.5.4 South and Central America Blood Brain Barrier Technologies Market Forecasts and Analysis - By Application
9.5.5 South and Central America Blood Brain Barrier Technologies Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Blood Brain Barrier Technologies Market
9.5.5.1.1 Brazil Blood Brain Barrier Technologies Market by Technology
9.5.5.1.2 Brazil Blood Brain Barrier Technologies Market by Application
9.5.5.2 Argentina Blood Brain Barrier Technologies Market
9.5.5.2.1 Argentina Blood Brain Barrier Technologies Market by Technology
9.5.5.2.2 Argentina Blood Brain Barrier Technologies Market by Application
9.5.5.3 Rest of South and Central America Blood Brain Barrier Technologies Market
9.5.5.3.1 Rest of South and Central America Blood Brain Barrier Technologies Market by Technology
9.5.5.3.2 Rest of South and Central America Blood Brain Barrier Technologies Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL BLOOD BRAIN BARRIER TECHNOLOGIES MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. BLOOD BRAIN BARRIER TECHNOLOGIES MARKET, KEY COMPANY PROFILES
12.1. TEVA PHARMACEUTICALS INDUSTRIES, LTD
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. F. HOFFMANN LA-ROCHE, LTD.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ELI LILLY AND COMPANY
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. FABRE-KRAMER PHARMACEUTICALS, INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. BRISTOL-MYERS SQUIBB COMPANY
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. PFIZER, INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. BIOASIA TECHNOLOGIES, INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. CYPRESS BIOSCIENCES, INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. JANSSEN PHARMACEUTICAL N.V.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. NEUROVIVE PHARMACEUTICAL AB
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Teva Pharmaceuticals Industries Ltd.
2. F. Hoffmann La-Roche Ltd.
3. Eli Lilly and Company
4. Fabre-Kramer Pharmaceuticals Inc.
5. Bristol-Myers Squibb Company
6. Pfizer Inc.
7. biOasia Technologies Inc.
8. Cypress Biosciences Inc.
9. Janssen Pharmaceutical N.V.
10. NeuroVive Pharmaceutical AB
TIPRE00021883
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking